Skip to content

General Catalyst Group Management, LLC 13F Holdings · Q2 2026

General Catalyst Group Management, LLC reported 14 securities worth $188.52M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: AVBP (27.55%), PBLS (23.24%), CART (17.85%). Among its top 25 positions this quarter: 4 new, 3 added, 1 trimmed, 2 exited.

RankTickerCompanyValue% PortfolioSharesAction
1AVBPArriVent BioPharma, Inc.$51.9M27.55%1.5MHold
2PBLSParabilis Medicines, Inc.$43.8M23.24%1.6MNew
3CARTMaplebear, Inc.$33.7M17.85%710,711Hold
4MAZEMaze Therapeutics, Inc.$30.9M16.40%1.0MHold
5ODTXOdyssey Therapeutics, Inc.$15.2M8.04%810,272New
6EIKNEikon Therapeutics, Inc.$4.0M2.11%305,233Hold
7GUTSFractyl Health, Inc.$3.9M2.06%4.9MTrimmed
8LIFEEthos Technologies, Inc.$1.3M0.71%74,179Hold
9CPNGCoupang Inc.$949,7390.50%54,677Added
10AMZNAmazon.com Inc.$925,2360.49%3,882Added
11METAMeta Platforms Inc.$743,5430.39%1,320Added
12DASHDoordash Inc.$525,9110.28%2,850New
13CVNACarvana Co$425,5260.23%6,465New
14FIGFigma, Inc.$268,5460.14%14,845Hold
15GTLBGITLAB INC$00.00%0Exited
16IOTSAMSARA INC$00.00%0Exited

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR